Published Date: Feb 10, 2021
The COVID-19 vaccination drive in Nepal is set to begin from Wednesday, following the arrival of vaccines from India. It has been learnt that 430,000 people will receive the vaccine during first phase of the COVID-19 vaccination drive in Nepal, which will last for about ten days. According to a recent report by BBC, Covishield is the Oxford-AstraZeneca vaccine which is being manufactured locally by the Serum Institute of India, the world's largest vaccine manufacturer. Oxford-AstraZeneca vaccine has been found to be 62-90 percent effective, while two dosages of the jab has to be administered between four and 12 weeks apart. India has donated 1 million dosage of the Covishield vaccine, which is the local name for the Oxford-AstraZeneca vaccine developed in the UK. It has been learnt that during the first phase of the campaign those who are at high risk of the infection will be injected the vaccine, especially frontline workers including health workers and staffers, security personnel, ambulance drivers, those working in waste management and sanitation, among others.
The latest information and advice for staff, prospective and current students during the current coronavirus pandemic. We Nagarjuna is closely monitoring developments and will continue to update you on the latest advice and guidance. Be Safe and Healthy. -Thank you!